In a new chapter of our long-standing partnership with esteemed neurologists, Ibn Al-Haytham organized a distinguished scientific gathering that brought together an elite group of leading neurologists, shedding light on innovative therapeutic options in neurological practice under the title “A New Chapter of a Shared Journey.”

The event featured key highlights that enriched the medical discussions:

🔹 Launch of Premium Products Enhancing Treatment Options:

• Privabolt, formulated with Brivaracetam—a next-generation antiepileptic drug to provide more precise and effective seizure control options.

• Super Age, the first national product with an advanced antioxidant formula, combining Acetyl-L-Carnitine and Alpha-Lipoic Acid to support multiple vital functions.

🔹 Scientific Horizons and Specialized Topics:

The sessions included a rich array of scientific lectures distributed across two main modules:

1. Expanding the horizons of using the next-generation antiepileptic drugs.

2. The role of supplements in neuropathy and how they have evolved into essential therapeutic adjuncts.

This meeting comes as a continuation of our enduring vision to build bridges of trust and genuine partnership with the medical staff, aiming to exchange expertise and elevate the quality of patients' lives.